Clinical Trials Browser

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT06031597 2023-09-13

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Phase 3 Unknown

105 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

NCT03085069 2023-02-16

A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC

Phase 2 Unknown

146 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Respiratory Tract Diseases

NCT05042375 2022-11-17

A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Phase 3 Unknown

450 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05532527 2022-09-08

NSCLC

Phase NA Unknown

35 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04749394 2022-08-16

A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

Phase 2 Unknown

42 enrolled

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT05472467 2022-07-25

IMCORT-2

Phase 2 Unknown

35 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04878107 2022-05-02

SABRE

Phase 2 Unknown

88 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04291092 2021-09-10

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Phase 2 Unknown

63 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04943029 2021-09-02

NEOSUN

Phase 2 Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05008861 2021-08-17

Gut Microbiota Reconstruction for NSCLC Immunotherapy

Phase 1 Unknown

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04950400 2021-07-06

A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC

Phase NA Unknown

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04541251 2021-06-23

Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC

Phase 2 Unknown

40 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04828395 2021-05-11

F&C

Phase 2 Unknown

65 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04793139 2021-03-11

Efficacy and Safety of Camrelizumab in Real-World Prospective Study

Unknown

1,000 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04631146 2020-11-17

Efficacy and Safety of Camrelizumab in Real-World Study

Unknown

450 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04102982 2020-11-02

MWA in NSCLC

Phase 2 Unknown

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04303130 2020-03-10

Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC

Phase 2 Unknown

52 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03557411 2020-02-05

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC

Phase 2 Unknown

42 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04167774 2019-11-22

Compass-001

Phase 2 Unknown

62 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04133337 2019-10-21

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Phase 1/2 Unknown

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT04108013 2019-09-27

A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC

Phase 2 Unknown

38 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03527251 2018-05-30

SEQUENCE

Phase 1 Unknown

10 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung